AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 60 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.19 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $4,043,000 | -26.0% | 6,475,084 | +0.1% | 0.00% | – |
| Q3 2019 | $5,460,000 | +5.7% | 6,465,605 | -15.7% | 0.00% | – |
| Q2 2019 | $5,164,000 | +4.0% | 7,670,096 | +26.7% | 0.00% | – |
| Q1 2019 | $4,966,000 | -40.7% | 6,055,294 | +15.7% | 0.00% | – |
| Q4 2018 | $8,377,000 | -50.0% | 5,235,279 | +3.3% | 0.00% | -100.0% |
| Q3 2018 | $16,770,000 | +48.6% | 5,066,360 | +1.5% | 0.00% | – |
| Q2 2018 | $11,284,000 | -13.9% | 4,992,841 | +10.5% | 0.00% | -100.0% |
| Q1 2018 | $13,105,000 | +7.9% | 4,519,201 | +3.8% | 0.00% | 0.0% |
| Q4 2017 | $12,151,000 | -21.9% | 4,355,097 | +2.1% | 0.00% | 0.0% |
| Q3 2017 | $15,563,000 | +97.4% | 4,263,918 | +20.1% | 0.00% | – |
| Q2 2017 | $7,884,000 | +459.1% | 3,551,360 | +48.6% | 0.00% | – |
| Q1 2017 | $1,410,000 | +6.1% | 2,389,128 | -2.9% | 0.00% | – |
| Q4 2016 | $1,329,000 | -38.3% | 2,459,746 | +1.6% | 0.00% | – |
| Q3 2016 | $2,154,000 | -9.3% | 2,420,586 | -2.0% | 0.00% | – |
| Q2 2016 | $2,374,000 | +5.6% | 2,470,485 | +1.1% | 0.00% | – |
| Q1 2016 | $2,248,000 | -23.1% | 2,443,181 | +5.2% | 0.00% | – |
| Q4 2015 | $2,925,000 | -98.4% | 2,321,807 | -74.3% | 0.00% | -100.0% |
| Q3 2015 | $182,494,000 | +4832.3% | 9,040,369 | +325.1% | 0.01% | – |
| Q2 2015 | $3,700,000 | +22.2% | 2,126,720 | +1.8% | 0.00% | – |
| Q1 2015 | $3,028,000 | +96.9% | 2,088,483 | +14.1% | 0.00% | – |
| Q4 2014 | $1,538,000 | -15.5% | 1,831,022 | +11.6% | 0.00% | – |
| Q3 2014 | $1,821,000 | -32.4% | 1,640,546 | +11.5% | 0.00% | – |
| Q2 2014 | $2,692,000 | +17.6% | 1,470,970 | -3.9% | 0.00% | – |
| Q1 2014 | $2,289,000 | -4.9% | 1,530,618 | +17.1% | 0.00% | – |
| Q4 2013 | $2,406,000 | -22.6% | 1,307,532 | -12.9% | 0.00% | – |
| Q3 2013 | $3,107,000 | -14.8% | 1,501,023 | +2.9% | 0.00% | – |
| Q2 2013 | $3,645,000 | – | 1,458,168 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
| GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
| Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
| Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
| Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
| Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
| Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
| Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
| Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
| TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |